FDA.reportPublic FDA data

Benzodiazepine group IVD, reagent

Definition
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of one or multiple benzodiazepines in a clinical specimen.
GUDID devices
20
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00895330002967Healgen (Private Label) - 564CONFIRM BIOSCIENCES, INC.CB-HE-5642022-12-19
04015630915514Serum BenzodiazepinesRoche Diagnostics GmbH207666903222016-09-20
04015630997695Benzodiazepines PlusRoche Diagnostics GmbH44990691902016-09-20
04015630997718Benzodiazepines PlusRoche Diagnostics GmbH44907891902016-09-23
07613336121054ONLINE DAT Benzodiazepines IIRoche Diagnostics GmbH080569271902023-05-11
04015630993475BenzodiazepinesRoche Diagnostics GmbH207379841222016-09-20
07613336170502ONLINE DAT Benzodiazepines PlusRoche Diagnostics GmbH080569191902020-03-05
00840937104613Immunalysis CorporationIMMUNALYSIS CORPORATIONPOS-214-22016-08-31
00840937104620Immunalysis CorporationIMMUNALYSIS CORPORATIONPOS-214-52016-08-31
00840937105405Immunalysis CorporationIMMUNALYSIS CORPORATIONCB-4142016-08-31
00840937105542Immunalysis CorporationIMMUNALYSIS CORPORATIONCB-4332016-08-31
00840937105771Immunalysis CorporationIMMUNALYSIS CORPORATIONCP-2142016-08-31
00840937105795Immunalysis CorporationIMMUNALYSIS CORPORATIONCP-2162016-08-31
00840937106525Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-214-252016-08-31
00840937106532Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-214-602016-08-31
00840937106549Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-214-7502016-08-31
00840937106563Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-216-152016-08-31
00840937106990Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-233-152016-08-31
00840937107003Immunalysis CorporationIMMUNALYSIS CORPORATIONFC-233-602016-08-31
05055273208023BENZRANDOX LABORATORIES LIMITEDDA40092016-09-24